Bennett, C. Frank
Ionis Pharmaceuticals (United States)
26 papers on CoChatORCID 0000-0001-9887-6251
Most cited papers
- Verified
Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB
Maimon, R., Chillon-Marinas, C., Snethlage, C. E., Singhal, S. M., McAlonis-Downes, M., Ling, K., Rigo, F., Bennett, C. F., Da Cruz, S., Hnasko, T. S., et al. (2021) · Nature Neuroscience
Neurogenesis and neuroplasticity mechanismsNeuroscience and Neuropharmacology Research
Cited by 62
- Verified
Effects of IONIS-HTTRx in Patients with Early Huntington’s Disease, Results of the First HTT-Lowering Drug Trial (CT.002)
Tabrizi, S., Leavitt, B., Kordasiewicz, H., Czech, C., Swayze, E., Norris, D. A., Baumann, T., Gerlach, I., Schobel, S., Smith, A., et al. (2018) · Neurology
Genetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free